| 产品详情 |
| Edit |   |
| Product Name | Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Recombinant, Human |
| Description | Purity ≥95%. Source: Recombinant Human from E. coli Purity: ≥95% Endotoxin: 1.0EU per 1ug (determined by the LAL method) Accession No: Q96IY4 Fragment: Glu138~Val423 (Accession No: Q96IY4) Sequence: MGHHHHHHSGSEF- ERH PDMLTKIHIG SSFEKYPLYV LKVSGKEQAA KNAIWIDCGI HAREWISPAF CLWFIGHITQ FYGIIGQYTN LLRLVDFYVM PVVNVDGYDY SWKKNRMWRK NRSFYANNHC IGTDLNRNFA SKHWCEEGAS SSSCSETYCG LYPESEPEVK AVASFLRRNI NQIKAYISMH SYSQHIVFPY SYTRSKSKDH EELSLVASEA VRAIEKISKN TRYTHGHGSE TLYLAPGGGD DWIYDLGIKY SFTIELRDTG TYGFLLPERY IKPTCREAFA AVSKIAWHVI RNV Epitope Tag: N-terminal His-Tag Molecular Weight: 34.5kD Applications: Suitable for use in ELISA, Western Blot, Immunoprecipitation, SDS-PAGE. |
| Size | 10ug, 50ug, 200ug |
| Concentration | n/a |
| Applications | n/a |
| Other Names | n/a |
| Gene, Accession, CAS # | SwissProt: Q96IY4 |
| Catalog # | 156975 |
| Price | |
| Order / More Info | Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Recombinant, Human from UNITED STATES BIOLOGICAL |
| Product Specific References | n/a |
| 产品资料 |
|
|